The process to harvest human embryonic stem cells (hESC) may be old news in the scientific community; however, the issues raised by this area of
In a unanimous decision released last Thursday (Apotex Inc. v. Sanofi‑Synthelabo Canada Inc., 2008 SCC 61), the Supreme Court of Canada confirmed that selection patents
Trying to get from point A to B can be frustrating, particularly when stuck in gridlock. A situation Michael Heller likens to the American (and
The following is based on the Globe and Mail article “Major companies agree to make anti-pollution patents public,” by Martin Mittelstadedt. Since January 2008 patents
Over the last thirty years, investment in the research and development of pharmaceuticals has risen dramatically. However, the availability of new drugs has not matched
The ideas that an inventor’s time and investments should be protected and new inventions encouraged through the granting of patents, underlie some of the justifications of
